What is the address of Spyridon STAMPOULOGLOU, dermatologue?

The registered office of Spyridon STAMPOULOGLOU, dermatologue is located at Chemin du Boiteux 4, 1380 Lasne.

Is Spyridon STAMPOULOGLOU, dermatologue still active?

Yes. According to the CBE (30 September 2026) Spyridon STAMPOULOGLOU, dermatologue is active, legal situation “Normale toestand”, started on 30 September 2016.

Is Spyridon STAMPOULOGLOU, dermatologue registered on Peppol?

Yes, Spyridon STAMPOULOGLOU, dermatologue is registered on the Peppol network with ID 0208:0663686470.

What is the enterprise number of Spyridon STAMPOULOGLOU, dermatologue?

The enterprise number of Spyridon STAMPOULOGLOU, dermatologue is BE0663686470.

When was Spyridon STAMPOULOGLOU, dermatologue founded?

Spyridon STAMPOULOGLOU, dermatologue was founded on 30 September 2016.

Is Spyridon STAMPOULOGLOU, dermatologue a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 September 2016; 5 annual accounts filed, latest fiscal year 2025.

How much profit did Spyridon STAMPOULOGLOU, dermatologue make in 2025?

Spyridon STAMPOULOGLOU, dermatologue posted a profit after taxes of € 101,717 in financial year 2025.

What is the revenue of Spyridon STAMPOULOGLOU, dermatologue?

As a small company, Spyridon STAMPOULOGLOU, dermatologue is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 138,273.

Spyridon STAMPOULOGLOU, dermatologue (Private Limited)

Dossier Spyridon STAMPOULOGLOU, dermatologue, printed on 30 September 2026 from databakkes.be/en/0663686470/spyridon-stampouloglou-dermatologue. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Spyridon STAMPOULOGLOU, dermatologue from Lasne, company number BE0663686470, closed financial year 2025 with a result of € 101,717 after tax. For that financial year Spyridon STAMPOULOGLOU, dermatologue recorded a gross margin of € 138,273 and equity of € 38,929. Compared with financial year 2024, the result moved from € 96,633 to € 101,717. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 38,929

▼ 29% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 101,717

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 30,996

▼ 43% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 117,647 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 8,597

▼ 43% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 103

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 57,900 Gross margin 2022: € 57,900 First fiscal year in the series	€ 88,274 Gross margin 2023: € 88,274 ▲ 52% vs 2022 (€ 57,900) Favourable step	€ 130,296 Gross margin 2024: € 130,296 ▲ 48% vs 2023 (€ 88,274) Favourable step	€ 138,273 Gross margin 2025: € 138,273 ▲ 6% vs 2024 (€ 130,296) Favourable step	▲ 6%
Profit after taxes	€ 42,074 Profit after taxes 2022: € 42,074 First fiscal year in the series	€ 63,901 Profit after taxes 2023: € 63,901 ▲ 52% vs 2022 (€ 42,074) Favourable step	€ 96,633 Profit after taxes 2024: € 96,633 ▲ 51% vs 2023 (€ 63,901) Favourable step	€ 101,717 Profit after taxes 2025: € 101,717 ▲ 5% vs 2024 (€ 96,633) Favourable step	▲ 5%
Equity	€ 66,485 Equity 2022: € 66,485 First fiscal year in the series	€ 52,740 Equity 2023: € 52,740 ▼ 21% vs 2022 (€ 66,485) Unfavourable step	€ 54,859 Equity 2024: € 54,859 ▲ 4% vs 2023 (€ 52,740) Favourable step	€ 38,929 Equity 2025: € 38,929 ▼ 29% vs 2024 (€ 54,859) Unfavourable step	▼ 29%
Total debts	€ 26,678 Total debts 2022: € 26,678 First fiscal year in the series	€ 17,005 Total debts 2023: € 17,005 ▼ 36% vs 2022 (€ 26,678) Favourable step	€ 19,457 Total debts 2024: € 19,457 ▲ 14% vs 2023 (€ 17,005) Unfavourable step	€ 3,262 Total debts 2025: € 3,262 ▼ 83% vs 2024 (€ 19,457) Favourable step	▼ 83%
Cash	€ 60,459 Cash 2022: € 60,459 First fiscal year in the series	€ 47,165 Cash 2023: € 47,165 ▼ 22% vs 2022 (€ 60,459) Unfavourable step	€ 54,355 Cash 2024: € 54,355 ▲ 15% vs 2023 (€ 47,165) Favourable step	€ 30,996 Cash 2025: € 30,996 ▼ 43% vs 2024 (€ 54,355) Unfavourable step	▼ 43%
Retained profit	€ 47,885 Retained profit 2022: € 47,885 First fiscal year in the series	€ 34,140 Retained profit 2023: € 34,140 ▼ 29% vs 2022 (€ 47,885) Unfavourable step	€ 36,259 Retained profit 2024: € 36,259 ▲ 6% vs 2023 (€ 34,140) Favourable step	€ 20,329 Retained profit 2025: € 20,329 ▼ 44% vs 2024 (€ 36,259) Unfavourable step	▼ 44%
Dividend	€ 88,235 Dividend 2022: € 88,235 First fiscal year in the series	€ 77,647 Dividend 2023: € 77,647 ▼ 12% vs 2022 (€ 88,235) Unchanged	€ 94,514 Dividend 2024: € 94,514 ▲ 22% vs 2023 (€ 77,647) Unchanged	€ 117,647 Dividend 2025: € 117,647 ▲ 24% vs 2024 (€ 94,514) Unchanged	▲ 24%
Balance sheet total	€ 93,163 Balance sheet total 2022: € 93,163 First fiscal year in the series	€ 69,745 Balance sheet total 2023: € 69,745 ▼ 25% vs 2022 (€ 93,163) Unchanged	€ 74,316 Balance sheet total 2024: € 74,316 ▲ 7% vs 2023 (€ 69,745) Unchanged	€ 42,191 Balance sheet total 2025: € 42,191 ▼ 43% vs 2024 (€ 74,316) Unchanged	▼ 43%

Key figures of Spyridon STAMPOULOGLOU, dermatologue, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Spyridon STAMPOULOGLOU, dermatologue?

What happened at Spyridon STAMPOULOGLOU, dermatologue in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 101,717 (▲ 5% vs 2024). Source: NBB ↗
Oct 1, 2016 New establishment in Lasne. KBO
Sep 30, 2016 Start of the company according to the CBE. KBO

In short

From € 42,074 profit in 2022 to € 101,717 profit in 2025.

Paid € 84,960 in corporate taxes since 2022.

Best year ever: 2025, with € 101,717 profit.

Paid out € 378,043 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Spyridon STAMPOULOGLOU, dermatologue? We notify you, reason included.

Follow Spyridon STAMPOULOGLOU, dermatologue

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin du Boiteux 4

1380 Lasne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0663.686.470
VAT number: BE 0663.686.470
Registered office: Chemin du Boiteux 4, 1380 Lasne
Names & denominations: Spyridon STAMPOULOGLOU, dermatologue
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 September 2016
Peppol: Active · Active since 30 Jun 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

Spyridon STAMPOULOGLOU, dermatologue